HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Pepti · Catalog · Tesamorelin + Ipamorelin Blend (10mg / 5mg)
Growth-hormone-axis blend · research-use
Tesamorelin + Ipamorelin blend OEM supply.
A single-vial co-lyophilate of stabilized-GHRH tesamorelin and selective-secretagogue ipamorelin, batch-documented by HPLC and MS for research and private-label programs.
Tesamorelin + IpamHPLC ≥ 98%MS confirmed15mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | Tesamorelin + Ipamorelin Blend (10mg / 5mg) |
|---|---|
| Class | Blends |
| Form | Lyophilized powder, sterile glass vial |
| Purity target | ≥ 98% by HPLC |
| Vial formats | 15mg |
| Documentation | COA + HPLC + MS, batch lot file where available |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder sealed at -20°C, protected from light and moisture; brief ambient transit is tolerated. After reconstitution, keep refrigerated at 2-8°C and use within the validated stability window. For laboratory research use only — not for human or veterinary use. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | From 50 vials | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Tesa10 + IPA5 is a research-use blend of 10 mg tesamorelin (a stabilized GHRH analog) and 5 mg ipamorelin (a selective ghrelin/GHS-receptor pentapeptide), co-lyophilized in a single 15 mg vial.
Documentation
Batch documentation support for Tesamorelin + Ipamorelin Blend (10mg / 5mg) lots.
COA / HPLC / MS document support where available. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the Tesamorelin + Ipamorelin Blend (10mg / 5mg) reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
Tesamorelin + Ipamorelin Blend (10mg / 5mg) — frequently asked by B2B buyers.
What exactly is in the "Tesa10 + IPA5" blend?
Each vial is co-lyophilized with 10 mg tesamorelin and 5 mg ipamorelin (15 mg total peptide) as a single mixed powder, not as two separate vials. The exact component identities and ratio are stated on the batch certificate of analysis.
Does the blend have its own CAS number or molecular weight?
No. A blend is a physical mixture, so it carries no single CAS number, molecular formula, or molecular weight. Documentation references each component's own identifiers instead: tesamorelin (CAS 218949-48-5, C221H366N72O67S, ~5135.9 g/mol) and ipamorelin (CAS 170851-70-4, C38H49N9O5, ~711.9 g/mol).
What purity and documentation ship with each batch?
Every lot is released with a certificate of analysis reporting HPLC purity and mass-spectrometry (MS) identity for both components. Additional third-party verification and testing (residual solvents, endotoxin, water content) can be arranged on request.
What vial size and MOQ apply for OEM orders?
The standard format is a 15 mg vial (10 mg tesamorelin / 5 mg ipamorelin) at an MOQ of 50 vials. Alternate ratios, fill weights, custom labeling, and private-label kitting are quoted on RFQ.
How is the blend supplied and shipped for B2B buyers?
It ships as a sterile-filtered lyophilized powder under cold-chain, with COA and, where required, export documentation. Material is supplied for laboratory and manufacturing research use only; buyers are responsible for compliance with import and end-use regulations in their jurisdiction.
Related compounds